APO Research
Talk to an analyst

APO RESEARCH · REPORT

Whole Exome Sequencing

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.

While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.

Selected research

Market Structure

Global Whole Exome Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026197 pages

Choose your research edition.

Industry ResearchWhole Exome Sequencing Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Whole Exome Sequencing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Whole Exome Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Whole Exome Sequencing Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Whole Exome Sequencing Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.

While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.

The major players in global Whole Exome Sequencing market include Illumina, Thermofisher, Roche, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Illumina TruSeq Exome and Roche Nimblegen SeqCap are main types, with a share about 55%. Mendelian Disease and Rare Syndrome Gene Discovery are the main application, which hold a share about 40%.

Read the full market overview

Report Includes

This report provides an overview of the global Whole Exome Sequencing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Whole Exome Sequencing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Whole Exome Sequencing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Whole Exome Sequencing market size, projected growth trends, production technologies, key applications, and end-use industries.

Whole Exome Sequencing Segment by Company

Illumina

Thermo Fisher

Roche

Angilent

Eurofins

Sengenics

Ambry

Macrogen

BGI

Novo Gene

Whole Exome Sequencing Segment by Type

Agilent HaloPlex

Agilent SureSelect

Agilent SureSelect QXT

Illumina TruSeq Exome

Roche Nimblegen SeqCap

MYcroarray MYbaits

Whole Exome Sequencing Segment by Application

Correlation Research of Normal Human

Mendelian Disease and Rare Syndrome Gene Discovery

The Research of Complex Diseases

Mouse Exome Sequencing

Whole Exome Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Exome Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Whole Exome Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Exome Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Whole Exome Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Whole Exome Sequencing industry.

Chapter 3: Detailed analysis of Whole Exome Sequencing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Whole Exome Sequencingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Whole Exome Sequencing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Agilent HaloPlex Table 3. Key Players of Agilent SureSelect Table 4. Key Players of Agilent SureSelect QXT Table 3. Key Players of Illumina TruSeq Exome Table 4. Key Players of Roche Nimblegen SeqCap Table 5. Key Players of MYcroarray MYbaits Table 6. Global Whole Exome Sequencing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Correlation Research of Normal Human Table 8. Key Players of Mendelian Disease and Rare Syndrome Gene Discovery Table 9. Key Players of The Research of Complex Diseases Table 10. Key Players of Mouse Exome Sequencing Table 11. Global Whole Exome Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Whole Exome Sequencing Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Whole Exome Sequencing Market Share by Region (2021-2026) Table 14. Global Whole Exome Sequencing Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Whole Exome Sequencing Market Share by Region (2027-2032) Table 16. Whole Exome Sequencing Industry Trends Table 17. Whole Exome Sequencing Industry Drivers Table 18. Whole Exome Sequencing Industry Opportunities and Challenges Table 19. Whole Exome Sequencing Industry Restraints Table 20. Global Whole Exome Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Whole Exome Sequencing Revenue Market Share by Company (2021-2026) Table 22. Global Whole Exome Sequencing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Whole Exome Sequencing Key Company Head Office and Area Served Table 24. Global Whole Exome Sequencing Company, Product Type & Application Table 25. Global Whole Exome Sequencing Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Whole Exome Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Whole Exome Sequencing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Whole Exome Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Whole Exome Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Whole Exome Sequencing Revenue Market Share by Type (2021-2026) Table 32. Global Whole Exome Sequencing Revenue Market Share by Type (2027-2032) Table 33. Global Whole Exome Sequencing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Whole Exome Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Whole Exome Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Whole Exome Sequencing Revenue Market Share by Application (2021-2026) Table 37. Global Whole Exome Sequencing Revenue Market Share by Application (2027-2032) Table 38. Illumina Company Information Table 39. Illumina Business Overview Table 40. Illumina Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Illumina Whole Exome Sequencing Product Portfolio Table 42. Illumina Recent Development Table 43. Thermo Fisher Company Information Table 44. Thermo Fisher Business Overview Table 45. Thermo Fisher Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Thermo Fisher Whole Exome Sequencing Product Portfolio Table 47. Thermo Fisher Recent Development Table 48. Roche Company Information Table 49. Roche Business Overview Table 50. Roche Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Roche Whole Exome Sequencing Product Portfolio Table 52. Roche Recent Development Table 53. Angilent Company Information Table 54. Angilent Business Overview Table 55. Angilent Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Angilent Whole Exome Sequencing Product Portfolio Table 57. Angilent Recent Development Table 58. Eurofins Company Information Table 59. Eurofins Business Overview Table 60. Eurofins Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Eurofins Whole Exome Sequencing Product Portfolio Table 62. Eurofins Recent Development Table 63. Sengenics Company Information Table 64. Sengenics Business Overview Table 65. Sengenics Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Sengenics Whole Exome Sequencing Product Portfolio Table 67. Sengenics Recent Development Table 68. Ambry Company Information Table 69. Ambry Business Overview Table 70. Ambry Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Ambry Whole Exome Sequencing Product Portfolio Table 72. Ambry Recent Development Table 73. Macrogen Company Information Table 74. Macrogen Business Overview Table 75. Macrogen Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Macrogen Whole Exome Sequencing Product Portfolio Table 77. Macrogen Recent Development Table 78. BGI Company Information Table 79. BGI Business Overview Table 80. BGI Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. BGI Whole Exome Sequencing Product Portfolio Table 82. BGI Recent Development Table 83. Novo Gene Company Information Table 84. Novo Gene Business Overview Table 85. Novo Gene Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Novo Gene Whole Exome Sequencing Product Portfolio Table 87. Novo Gene Recent Development Table 88. North America Whole Exome Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 89. North America Whole Exome Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 90. North America Whole Exome Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 91. North America Whole Exome Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 92. North America Whole Exome Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. North America Whole Exome Sequencing Market Size by Country (2021-2026) Table 94. North America Whole Exome Sequencing Market Size by Country (2027-2032) Table 95. Europe Whole Exome Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 96. Europe Whole Exome Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 97. Europe Whole Exome Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 98. Europe Whole Exome Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 99. Europe Whole Exome Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Europe Whole Exome Sequencing Market Size by Country (2021-2026) Table 101. Europe Whole Exome Sequencing Market Size by Country (2027-2032) Table 102. China Whole Exome Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 103. China Whole Exome Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 104. China Whole Exome Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 105. China Whole Exome Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 106. Asia Whole Exome Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 107. Asia Whole Exome Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 108. Asia Whole Exome Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 109. Asia Whole Exome Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 110. Asia Whole Exome Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Asia Whole Exome Sequencing Market Size by Country (2021-2026) Table 112. Asia Whole Exome Sequencing Market Size by Country (2027-2032) Table 113. South America, Middle East & Africa Whole Exome Sequencing Market Size by Type (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa Whole Exome Sequencing Market Size by Type (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa Whole Exome Sequencing Market Size by Application (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Whole Exome Sequencing Market Size by Application (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Whole Exome Sequencing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. South America, Middle East & Africa Whole Exome Sequencing Market Size by Country (2021-2026) Table 119. South America, Middle East & Africa Whole Exome Sequencing Market Size by Country (2027-2032) Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Whole Exome Sequencing Product Image Figure 2. Global Whole Exome Sequencing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Whole Exome Sequencing Market Share by Type: 2025 VS 2032 Figure 4. Agilent HaloPlex Image Figure 5. Agilent SureSelect Image Figure 6. Agilent SureSelect QXT Image Figure 7. Illumina TruSeq Exome Image Figure 8. Roche Nimblegen SeqCap Image Figure 9. MYcroarray MYbaits Image Figure 10. Global Whole Exome Sequencing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Whole Exome Sequencing Market Share by Application: 2025 VS 2032 Figure 12. Correlation Research of Normal Human Image Figure 13. Mendelian Disease and Rare Syndrome Gene Discovery Image Figure 14. The Research of Complex Diseases Image Figure 15. Mouse Exome Sequencing Image Figure 16. Global Whole Exome Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 18. Global Whole Exome Sequencing Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Whole Exome Sequencing Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Whole Exome Sequencing Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Whole Exome Sequencing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Whole Exome Sequencing Revenue Market Share by Type (2021-2032) Figure 25. Global Whole Exome Sequencing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Whole Exome Sequencing Revenue Market Share by Application (2021-2032) Figure 27. North America Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 28. North America Whole Exome Sequencing Market Share by Type (2021-2032) Figure 29. North America Whole Exome Sequencing Market Share by Application (2021-2032) Figure 30. North America Whole Exome Sequencing Market Share by Country (2021-2032) Figure 31. United States Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 32. Canada Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 34. Europe Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 35. Europe Whole Exome Sequencing Market Share by Type (2021-2032) Figure 36. Europe Whole Exome Sequencing Market Share by Application (2021-2032) Figure 37. Europe Whole Exome Sequencing Market Share by Country (2021-2032) Figure 38. Germany Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 39. France Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 41. Italy Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 42. Russia Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 44. China Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 45. China Whole Exome Sequencing Market Share by Type (2021-2032) Figure 46. China Whole Exome Sequencing Market Share by Application (2021-2032) Figure 47. Asia Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 48. Asia Whole Exome Sequencing Market Share by Type (2021-2032) Figure 49. Asia Whole Exome Sequencing Market Share by Application (2021-2032) Figure 50. Asia Whole Exome Sequencing Market Share by Country (2021-2032) Figure 51. Japan Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 55. India Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 56. Australia Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Whole Exome Sequencing Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Whole Exome Sequencing Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Whole Exome Sequencing Market Share by Country (2021-2032) Figure 61. Brazil Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 66. UAE Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 68. Chile Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Agilent HaloPlex
  • Agilent SureSelect
  • Agilent SureSelect QXT
  • Illumina TruSeq Exome
  • Roche Nimblegen SeqCap
  • MYcroarray MYbaits
Applications
  • Correlation Research of Normal Human
  • Mendelian Disease and Rare Syndrome Gene Discovery
  • The Research of Complex Diseases
  • Mouse Exome Sequencing
Companies covered
  • Illumina
  • Thermo Fisher
  • Roche
  • Angilent
  • Eurofins
  • Sengenics
  • Ambry
  • Macrogen
  • BGI
  • Novo Gene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Whole Exome Sequencing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Agilent HaloPlex
  5. 1.2.3 Agilent SureSelect
  6. 1.2.4 Agilent SureSelect QXT
  7. 1.2.5 Illumina TruSeq Exome
  8. 1.2.6 Roche Nimblegen SeqCap
  9. 1.2.7 MYcroarray MYbaits
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Whole Exome Sequencing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Correlation Research of Normal Human
  13. 1.3.3 Mendelian Disease and Rare Syndrome Gene Discovery
  14. 1.3.4 The Research of Complex Diseases
  15. 1.3.5 Mouse Exome Sequencing
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Whole Exome Sequencing Growth Trends by Region
  18. 1.5.1 Global Whole Exome Sequencing Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Whole Exome Sequencing Market Size by Region (2021-2026)
  20. 1.5.3 Whole Exome Sequencing Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Whole Exome Sequencing Market Dynamics
  1. 2.1 Whole Exome Sequencing Industry Trends
  2. 2.2 Whole Exome Sequencing Industry Drivers
  3. 2.3 Whole Exome Sequencing Industry Opportunities and Challenges
  4. 2.4 Whole Exome Sequencing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Whole Exome Sequencing Revenue by Company (2021-2026)
  2. 3.2 Global Whole Exome Sequencing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Whole Exome Sequencing Key Company Head office and Area Served
  4. 3.4 Global Whole Exome Sequencing Company, Product Type & Application
  5. 3.5 Global Whole Exome Sequencing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Whole Exome Sequencing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Whole Exome Sequencing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Whole Exome Sequencing Tier 1, Tier 2, and Tier 3
4 Whole Exome Sequencing Market by Type
  1. 4.1 Global Whole Exome Sequencing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Whole Exome Sequencing Market Size by Type (2021-2032)
  3. 4.3 Global Whole Exome Sequencing Market Size Share by Type (2021-2032)
5 Whole Exome Sequencing Market by Application
  1. 5.1 Global Whole Exome Sequencing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Whole Exome Sequencing Market Size by Application (2021-2032)
  3. 5.3 Global Whole Exome Sequencing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Illumina
  2. 6.1.1 Illumina Company Information
  3. 6.1.2 Illumina Business Overview
  4. 6.1.3 Illumina Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Illumina Whole Exome Sequencing Product Portfolio
  6. 6.1.5 Illumina Recent Developments
  7. 6.2 Thermo Fisher
  8. 6.2.1 Thermo Fisher Company Information
  9. 6.2.2 Thermo Fisher Business Overview
  10. 6.2.3 Thermo Fisher Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Thermo Fisher Whole Exome Sequencing Product Portfolio
  12. 6.2.5 Thermo Fisher Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Roche Whole Exome Sequencing Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Angilent
  20. 6.4.1 Angilent Company Information
  21. 6.4.2 Angilent Business Overview
  22. 6.4.3 Angilent Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Angilent Whole Exome Sequencing Product Portfolio
  24. 6.4.5 Angilent Recent Developments
  25. 6.5 Eurofins
  26. 6.5.1 Eurofins Company Information
  27. 6.5.2 Eurofins Business Overview
  28. 6.5.3 Eurofins Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Eurofins Whole Exome Sequencing Product Portfolio
  30. 6.5.5 Eurofins Recent Developments
  31. 6.6 Sengenics
  32. 6.6.1 Sengenics Company Information
  33. 6.6.2 Sengenics Business Overview
  34. 6.6.3 Sengenics Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Sengenics Whole Exome Sequencing Product Portfolio
  36. 6.6.5 Sengenics Recent Developments
  37. 6.7 Ambry
  38. 6.7.1 Ambry Company Information
  39. 6.7.2 Ambry Business Overview
  40. 6.7.3 Ambry Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Ambry Whole Exome Sequencing Product Portfolio
  42. 6.7.5 Ambry Recent Developments
  43. 6.8 Macrogen
  44. 6.8.1 Macrogen Company Information
  45. 6.8.2 Macrogen Business Overview
  46. 6.8.3 Macrogen Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Macrogen Whole Exome Sequencing Product Portfolio
  48. 6.8.5 Macrogen Recent Developments
  49. 6.9 BGI
  50. 6.9.1 BGI Company Information
  51. 6.9.2 BGI Business Overview
  52. 6.9.3 BGI Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 BGI Whole Exome Sequencing Product Portfolio
  54. 6.9.5 BGI Recent Developments
  55. 6.10 Novo Gene
  56. 6.10.1 Novo Gene Company Information
  57. 6.10.2 Novo Gene Business Overview
  58. 6.10.3 Novo Gene Whole Exome Sequencing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Novo Gene Whole Exome Sequencing Product Portfolio
  60. 6.10.5 Novo Gene Recent Developments
7 North America
  1. 7.1 North America Whole Exome Sequencing Market Size (2021-2032)
  2. 7.2 North America Whole Exome Sequencing Market Size by Type
  3. 7.2.1 North America Whole Exome Sequencing Market Size by Type (2021-2026)
  4. 7.2.2 North America Whole Exome Sequencing Market Size by Type (2027-2032)
  5. 7.2.3 North America Whole Exome Sequencing Market Share by Type (2021-2032)
  6. 7.3 North America Whole Exome Sequencing Market Size by Application
  7. 7.3.1 North America Whole Exome Sequencing Market Size by Application (2021-2026)
  8. 7.3.2 North America Whole Exome Sequencing Market Size by Application (2027-2032)
  9. 7.3.3 North America Whole Exome Sequencing Market Share by Application (2021-2032)
  10. 7.4 North America Whole Exome Sequencing Market Size by Country
  11. 7.4.1 North America Whole Exome Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Whole Exome Sequencing Market Size by Country (2021-2026)
  13. 7.4.3 North America Whole Exome Sequencing Market Size by Country (2027-2032)
  14. 7.4.4 North America Whole Exome Sequencing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Whole Exome Sequencing Market Size (2021-2032)
  2. 8.2 Europe Whole Exome Sequencing Market Size by Type
  3. 8.2.1 Europe Whole Exome Sequencing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Whole Exome Sequencing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Whole Exome Sequencing Market Share by Type (2021-2032)
  6. 8.3 Europe Whole Exome Sequencing Market Size by Application
  7. 8.3.1 Europe Whole Exome Sequencing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Whole Exome Sequencing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Whole Exome Sequencing Market Share by Application (2021-2032)
  10. 8.4 Europe Whole Exome Sequencing Market Size by Country
  11. 8.4.1 Europe Whole Exome Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Whole Exome Sequencing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Whole Exome Sequencing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Whole Exome Sequencing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Whole Exome Sequencing Market Size (2021-2032)
  2. 9.2 China Whole Exome Sequencing Market Size by Type
  3. 9.2.1 China Whole Exome Sequencing Market Size by Type (2021-2026)
  4. 9.2.2 China Whole Exome Sequencing Market Size by Type (2027-2032)
  5. 9.2.3 China Whole Exome Sequencing Market Share by Type (2021-2032)
  6. 9.3 China Whole Exome Sequencing Market Size by Application
  7. 9.3.1 China Whole Exome Sequencing Market Size by Application (2021-2026)
  8. 9.3.2 China Whole Exome Sequencing Market Size by Application (2027-2032)
  9. 9.3.3 China Whole Exome Sequencing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Whole Exome Sequencing Market Size (2021-2032)
  2. 10.2 Asia Whole Exome Sequencing Market Size by Type
  3. 10.2.1 Asia Whole Exome Sequencing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Whole Exome Sequencing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Whole Exome Sequencing Market Share by Type (2021-2032)
  6. 10.3 Asia Whole Exome Sequencing Market Size by Application
  7. 10.3.1 Asia Whole Exome Sequencing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Whole Exome Sequencing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Whole Exome Sequencing Market Share by Application (2021-2032)
  10. 10.4 Asia Whole Exome Sequencing Market Size by Country
  11. 10.4.1 Asia Whole Exome Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Whole Exome Sequencing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Whole Exome Sequencing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Whole Exome Sequencing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Whole Exome Sequencing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Whole Exome Sequencing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Whole Exome Sequencing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Whole Exome Sequencing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Whole Exome Sequencing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Whole Exome Sequencing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Whole Exome Sequencing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Whole Exome Sequencing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Whole Exome Sequencing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Whole Exome Sequencing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Whole Exome Sequencing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Whole Exome Sequencing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Whole Exome Sequencing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Whole Exome Sequencing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst